AstraZeneca’s COVID-19 antibody jab approved for adults medically unsuitable for vaccination: HSA

SINGAPORE: The Health Sciences Authority (HSA) on Monday (Aug 1) granted temporary authorisation for AstraZeneca’s COVID-19 antibody medication for adults who are medically unsuitable for vaccination against the coronavirus. The Evusheld treatment comprises  2 monoclonal antibodies and it is administered via intramuscular injection.   HSA said the treatment is approvedContinue Reading

MAS losses due to currency translation effect, does not affect investment and Government’s budget: Lawrence Wong

Addressing queries about the impact on the Government’s budget placement, Mr Wong very first pointed out that the Government does not expect MAS in order to deviate from its require of ensuring macroeconomic stability in order to maximise the contributions to the open public coffers. One of the ways inContinue Reading